Rivastigmine Sandoz-H-C-PSUSA-00002654-202401: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation
Rivastigmine Sandoz-H-C-PSUSA-00002654-202401: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation
Advanced pharmaceutical formulation for targeted therapeutic intervention.
Dosage
Rivastigmine Sandoz-H-C-PSUSA-00002654-202401: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation
Strength
Rivastigmine Sandoz-H-C-PSUSA-00002654-202401: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation
Pack Size
Rivastigmine Sandoz-H-C-PSUSA-00002654-202401: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation
Form
Rivastigmine Sandoz-H-C-PSUSA-00002654-202401: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation
Source
European Medicines Agency
